SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Intellikine, Inc., a Leading Developer of Small Molecule Drugs Targeting the PI3K/mTOR Pathway, Names Dr. Gregory Berk Chief Medical Officer